non-therapeutic use of cells, genes, genetic elements or the modulation of gene expression having the capacity to enhance athletic performance, is prohibited. EPO, hGH, insulin-like growth factor-1 (IGF-1), peroxisome proliferator-activated receptor-delta (PPAR delta) and myostatin inhibitor genes have been identified as primary targets for gene doping.
Besides making the competitions unfair, gene doping puts the athletes health in great danger. Risks associated with gene doping fall into two main areas:
First, the product and the procedures for delivery of the product are risky. The production of viral vectors requires considerable purification and testing for replication-competent viruses. Secondly, the uncontrolled expression of the genes may itself be harmful.
At present, detection of doping in sport is based on two approaches. The main and currently most important approach is the detection of the specific substance itself and the second approach is the detection of the consequences of administering the doping agent.
Recombinant proteins such as EPO and hGH can be detected by analysis of the isoforms of these hormones. However, genetic modifications will be very difficult to detect. For example, expression of antisense reagents within muscles to reduce the levels of myostatin will be hard to detect, as levels of circulating myostatin are low in man. Detection of transferred genetic materials may pose a problem, as current doping detection relies on urine and blood samples and it is generally considered that any form of tissue biopsy would be unacceptable.
Since no actual abuse of gene doping has been documented so far, the prospects for gene doping remains essentially theoretical at present. However, this field as a whole should continue to be closely monitored. Despite the risks associated with untested gene-doping procedures and products, it seems quite possible that some athletes will be tempted to experience this type of doping.
In order to pre-empt any possible exploitation of gene doping and recombinant drugs, extensive research is clearly required in these fields to ensure that competent and reliable methods are developed for the containment of these new trends of drug and therapeutic abuses in sport. 
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